Filter
9633
Filtered Results: 9633
Text search:
Disease
Prevention
&
Control
Featured
Recommendations
927
New Publications
2327
Language
Document type
No document type
4973
Guidelines
1513
Studies & Reports
1456
Manuals
448
Fact sheets
369
Strategic & Response Plan
339
Training Material
139
Infographics
102
Resource Platforms
96
Situation Updates
93
Online Courses
45
Brochures
34
Videos
17
Dashboards/Maps
7
App
2
Countries / Regions
Global
453
India
382
Sierra Leone
248
Kenya
228
Liberia
220
Western and Central Europe
212
Africa
194
Nigeria
189
Ethiopia
185
Latin America and the Carribbean
182
South Africa
173
Uganda
142
Congo, Democratic Republic of
140
Rwanda
121
Nepal
119
Guinea
118
West and Central Africa
111
Malawi
110
Senegal
107
Zambia
105
Tanzania
105
Mozambique
103
Middle East and North Africa
102
Ghana
100
Syria
95
East and Southern Africa
89
Russia
88
Bangladesh
85
Myanmar / Burma
83
Haiti
81
Ukraine
81
Brazil
79
South Sudan
75
Burkina Faso
73
Philippines
72
Eastern Europe
71
Namibia
69
Germany
65
South–East Asia Region
61
Yemen
60
Mali
54
Zimbabwe
52
Colombia
52
Asia
52
Guinea-Bissau
49
Côte d’Ivoire / Ivory Coast
49
Angola
47
Cameroon
45
Lesotho
45
Indonesia
43
Eastern Europe and Central Asia
41
Cambodia
40
Venezuela
36
Paraguay
33
Chad
32
Niger
28
Botswana
28
Eswatini/ Swaziland
27
Madagascar
27
USA
24
Chile
24
Pakistan
23
Argentina
23
Peru
23
Benin
22
Bolivia
22
Ecuador
21
Western Pacific Region
21
Somalia
20
Afghanistan
20
Central African Republic
20
Sudan
19
Vietnam
17
Spain
17
Thailand
16
China
15
Tajikistan
14
Iraq
13
Togo
12
Lebanon
12
Albania
12
Moldova
12
North America
12
Saudi Arabia
10
Jordan
10
Egypt
10
Laos
9
Georgia
9
Portugal
9
Burundi
8
Mexico
8
Sri Lanka
8
Turkey
7
North Macedonia
7
El Salvador
7
Palestine
7
Armenia
6
Southern Africa
6
Timor Leste/ East Timor
6
France
6
Gambia
5
Papua New Guinea
5
Honduras
5
Bhutan
5
Poland
5
Romania
5
Kazakhstan
5
Uruguay
5
United Kingdom
5
Hungary
4
Libya
4
Italy
4
Djibouti
4
Congo-Brazzaville
4
Canada
4
Iran
4
Turkmenistan
4
Japan
4
Belarus
4
Malaysia
3
Singapore
3
Dominican Republic
3
Uzbekistan
3
Kyrgyzstan
3
Gabon
3
Jamaica
3
Mauritius
3
Tunisia
3
Morocco
2
Mauritania
2
Serbia
2
Greece
2
Guatemala
2
Other region
2
North Korea
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
Belgium
2
South Korea
2
Israel
2
Bosnia and Herzegovina
2
Ireland
1
Austria
1
Switzerland
1
Cuba
1
Cape Verde
1
Nicaragua
1
Fiji
1
Mongolia
1
Lithuania
1
Australia
1
Denmark
1
Maldives
1
Morocco
1
Azerbaijan
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3453
Clinical Guidelines
811
Public Health
621
Key Resources
395
Women & Child Health
350
Capacity Building
150
Pharmacy & Technologies
109
Annual Report MEDBOX
2
Toolboxes
COVID-19
1360
HIV
679
TB
615
Mental Health
560
Ebola
537
Rapid Response
402
AMR
374
NTDs
334
NCDs
283
Planetary Health
267
Caregiver
220
Zika
174
Refugee
158
Conflict
150
Global Health Education
124
Cholera
122
Disability
121
Pharmacy
117
Natural Hazards
89
Health Financing Toolbox
67
Polio
62
Specific Hazards
56
Social Ethics
11
Typhoon
3
Health Financing
3
South Sudan
2
This guidance document is based on research of social media activity related to antibiotic use at EU level, as well as on a survey of the social media activities of EAAD partner organisations, mostly EU umbrella organisations of patients and health professionals. The research showed that there is al...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of C...
Key messages for professionals working at hospitals and other healthcare settings: managers/administrators, infectious disease specialists, infection prevention and ... professionals, epidemiologists, prescribers, junior doctors and students, pharmacists, nurses, clinical microbiologists, and professionals in emergency departments, in intensive care units, and in long-term care facilities.
This document provides guidance for African Union Member States on actions to be taken to ensure they continue to meet all the health
needs of their citizens in accordance with achieving the objectives of the Africa Health Strategy 2016 – 2030.
In response to the first cases of coronavirus disease 2019 (COVID-19) reported on the continent, many African Union Member States implemented large-scale public health and social measures (PHSM) rapidly. These measures were aimed at reducing transmi...
Guidance on easing lockdown in Arabic Version
]. تختلف مخاطر التلوث COVID-19المادية في سياق جائحة مرض فيروس كـــورونـا المستجد [السطحي وانتقال العدوى باختلاف نوع الإعداد وحجم السكان الذين يترددون على كل مكان (مثل: م...
These guidelines outline the minimum operational guidance for infection prevention and control (IPC) in ambulances transferring suspected or confirmed COVID-19 patients. Ambulance staff should be tr...
Caregivers provide invaluable service and support to patients in health facilities. In many health systems, caregivers (often members of the patient’s family or friends) are responsible for providing basic care for a patient, including providing food and drinks, cleaning clothes and bed linen, as ...
Health care waste can be difficult to treat and dispose of safely. The environmental and health impacts of waste put extra pressure on resources. Therefore, it is important to try and reduce the quantities of waste wherever possible. Ensure waste is segregated properly at the point of disposal. It i...
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguar...
The application of digital health technology is growing at a rapid rate in Africa, with the goals of improving the delivery of healthcare services and more effectively reaching out to remote and underserved communities. The lack of enabling guidelines and standards across the continent, on the other...
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 201...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance ... 2020 – 2025, which is tailored to meet the specific needs of African nations through a coordinated approach. While most countries in the region have developed and prioritized National Action Plans (NAPs) to tackle AMR, the overall response remains inadequate given the magnitude of the threat, which endangers human, animal, environmental, aquatic, and plant health.
Africa bears a significant burden of infectious diseases, accounting for approximately 95% of malaria deaths, 70% of people living with HIV, and 25% of TB deaths globally. In 2019, AMR was linked to approximately 55,000 deaths from HIV, 30,000 from malaria, and 255,000 overall. Major drivers of AMR in the region include the overuse and misuse of antimicrobials in human and food systems, migration, suboptimal vaccination rates, and environmental contamination from hospital and pharmaceutical effluents. Additionally, there is a lack of access to quality-assured antimicrobials and diagnostics, compounded by inadequate knowledge about AMR. Unlike high-income countries, where indiscriminate antimicrobial use is the primary factor driving AMR, African countries face additional challenges, including a lack of access to clean and safe water, poor Water, Sanitation, and Hygiene (WASH) programs, inadequate infection prevention measures, and suboptimal vaccinations for preventable diseases. One in three hospitals in the region lacks clean, safe running water, and one in eight people defecate openly due to inadequate sanitation. Investments in WASH, infection prevention, and biosecurity could save approximately 700,000 lives annually.
Addressing AMR in Africa requires a comprehensive, multi-sectoral approach involving the entire society. Sustainable access to antimicrobials, including antibiotics, vaccines, and therapeutics, is crucial, as lack of access leads to more morbidity and mortality than AMR itself. Support for the region should focus on preventing infections, strengthening health and food systems, developing human resources, ensuring sustainable access to diagnostics and therapeutics, and investing in laboratory infrastructure to support surveillance and data generation.
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like ... occurred in monkeys kept for research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
Let's Stop HIV together
Accessed: 19.10.2019
Let's Stop HIV together
Accessed: 19.10.2019
